The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis

Scandinavian Journal of Immunology

Volumn 70, Issue 4, 2009, Pages 403-407

  Montanheiro, P A ^a   Penalva De Oliveira, A C ^b   Smid, J ^b   Fukumori, L M I ^a   Olah, I ^a   Duarte, A J Da S ^a   Casseb, J ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE SYSTEM; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS CARRIER;

EID: 70049087509     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02291.x     Document Type: Article

References (23)

1. Gessain A, Barin F, Vernant JC et al. Antibodies to human T-lymphotropic virus type I in patient with tropical spastic paraparesis. Lancet 1985 2 : 407 410.
2. Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy: a new clinical entity. Lancet 1986 1 : 1031 1032. (Pubitemid 16102987)
3. Takatsumi K, Uchiyama T, Sagawa K, Yodoi J. In Seno (es) topics in hematology. Amst Excerpta Medica 1977 1 : 73 7.
4. Uchiyama T. Human T-cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997 15 : 15 37.
5. Hinuma Y, Cómoda H, Chosa T, et al. Antibodies to adult T-cell leucemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982 29 : 631 635.
6. Mochizuki M, Watanabe T, Yamaguchi K et al. Uveitis associated with human T-cell lymphotropic virus type I: seroepidemiologic, clinical and virologic studies. J Infect Dis 1992 166 : 943 944.
7. Cruz BA, Catalan-Soares B, Proietti F. Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I. J Rheumatol 2006 33 : 2300 2303.
8. Miyazawa M, Takahashi S, Kawaguchi H et al. Low expression of adhesion molecules in a case of cutaneous T-cell lymphoma. J Dermatol 1995 22 : 659 664.
9. Smadja D, Bellance R, Cabre P, Kerjean J, Lezin A, Vernant JC. Atteintes du système nerveux périphérique et du muscle squelettique au cours des paraplégies associées au vírus HTLV-I; etude de 70 cas observes em Martinique. Ver Neurol (Paris) 1995 151 : 190 195.
10. Nishioka K, Maruyama I, Sato K, Kitajima I, Makajima Y, Osame M. Chronic Inflammatory arthropathy associated with HTLV-I. Histopathology 1989 7 : 349 364.
11. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA. Interdisciplinary HTLV Research Group. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saude Publica 2005 21 : 926 931.
12. Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8 + T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 2001 50 : 807 812.
13. Jacobson S. Immunopathogenesis of HTLV-I-associated neurologic disease. J Infect Dis 2002 186 (suppl 2 S187 92.
14. Roman GC. Retrovirus-associated myelopathies. Intern Med 2001 40 : 14 7.
15. Hollesberg P, Hafler DA. Pathogenesis of diseases induced by HTLV-I Infection. N Engl J Med 1993 328 : 1173 1182.
16. Ferreira JOC, Planelles V, Rosenblatt JD. Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 1997 11 : 91 104.
17. Franchini G. Molecular mechanisms of HTLV-I. Blood 1995 86 : 1619 1639.
18. Montanheiro P, Penalva-de-Oliveira A, Posada-Vergada MP et al. HTLV-I proviral DNA viral load among asymptomatic patients and patients with TSP/HAM. Braz J Med Biol Res 2005 38 : 1643 1647.
19. Höllsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999 63 : 308 333.
20. Hanon E, Goon P, Taylor GP et al. High production of IFN-γ but not IL-2 by human T-lymphotropic virus type I-Infected peripheral blood mononuclear cells. Blood 2001 98 : 721 726.
21. Brito-Melo GE, Peruhype-Magalhães V, Teixeira-Carvalho A et al. IL-10 produced by CD4 + and CD8 + T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clin Exp Immunol 2007 147 : 35 44.
22. Sabouri AH, Usuku K, Hayashi D et al. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8 + T cells in HTLV-1-associated neurologic disease. Blood 2008 112 : 2411 2420.
23. Croda MG, de Oliveira AC, Vergara MP et al. Corticosteroid therapy in TSP/HAM patients: the results from a 10 years open cohort. J Neurol Sci 2008 269 : 133 137.